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Background: Identifying modifications made to terminal parts of proteins are very useful in 
understanding diseases and other out of the ordinary biological states. This thesis has focused 
on developing methods for enriching N-terminal and C-terminal peptides from a complex 
protein mixture, so that analysis of these samples can give better, more comprehensive and 
more reproducible results.  
 
Materials and methods: This thesis applies a bottom-up proteomics work-flow approach to 
develop and compare methods for enrichment of N-terminal peptides, using two digestion 
enzymes, three sample clean-up methods, and two enrichment mediums in different 
combinations. One method for C-terminal enrichment was developed, with basis in the method 
that gave the best results from N-terminal enrichment. 
 
Results and discussion: None of the N-terminal enrichment methods improved the number of 
terminal peptides compared to the control samples. However, the results suggest that trypsin 
should be the enzyme of choice when enriching for N-terminal 
The method for enrichment of C-terminal peptides was developed with basis in the method that 
gave the best results for the N-terminal enrichment. This method yielded only one terminal 
peptide, which is far lower than expected based on existing literature. 
 
Conclusion: Due to one or more unknown factors that are not under control, none of the 
methods developed in this thesis improves the number of terminal peptides. These methods are 








Proteomics is the study the of proteome, or the proteins that can be found in an organism. 
Through proteomics we hope to further understand both structure and function of the various 
proteins that can be found in the cell(s) of an organism, and by extent the cell and the organism 
itself1. 
 
1.2 Protein Biology 
The central dogma of biology states that once genetic information has been translated to a 
protein, it cannot be translated back to DNA/RNA or replicated to create a new protein2, as 
illustrated in Figure 1-13. 
 
 
Figure 1-1: The Central Dogma of Molecular Biology 
 
There are only 20 amino acids commonly coded for in the DNA. All of these are α-amino acids, 
meaning that they have an amine and a carboxylic acid connected to the same carbon — the α-
carbon. These three constituents make up the main chain of the amino acid, and they are the 
same for all the 20 common amino acids. What makes each amino acid unique is its side chain. 
The side chain can be small and simple, a hydrogen in glycine — the smallest amino acid — or 
it can be large and complex, like the indole ring system found in tryptophan — the largest of 
the common amino acids. All the common amino acids, except for proline, have the same 
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generic structure. Proline has a cyclic structure, where the side chain is attached to both the α-
carbon and the amine, making it the only common amino acid without a primary amine4. Both 
proline and the generic amino acid structure can be seen in Figure 1-2. The main chain of the 
amino acids can be joined together by a condensation reaction, amine to carboxyl-carbon, which 
forms a peptide. As more and more amino acids are added to the peptide, it gains specific 
properties and starts folding itself to gain secondary and tertiary structures, and becomes a 
polypeptide or a protein. The primary structure is the amino acid sequence itself. Separate 
polypeptide/protein chains can also join together, by covalent or non-covalent bonds, and create 
a quaternary structure4. 
 
 
Figure 1-2: Generic α-amino acid structure on the left. Proline on the right.  
 
After translation, proteins may be modified in order to change or activate their effects. This is 
often achieved by removing certain amino acids, or by adding different functional groups to 
them. These post translational modifications (PTMs) are important in the regulation of the 
activity of proteins, and can be important in various diseases and biological states1. 
 
1.2.1 Information found in terminal peptides 
Changes made in the terminal parts of proteins often mean a change in location, conformation 
or activity for the protein.  
An example of this is the protein oncostatin M (OSM), a cytokine in the interleukin-6 
subfamily, with activities related to e.g. tumour growth, haematopoiesis, inflammation and 
bone growth5–7. 
The first 25 amino acids on the N-terminal side of OSM form a hydrophobic signal peptide. 
This peptide signals for secretion of the protein, and is cleaved off during the secretion8. On the 
C-terminal side, OSM has a hydrophilic pro-peptide consisting of 30 amino acids that is 
removed during maturation of the protein. The presence of this pro-peptide is shown to have 
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little effect on the receptor binding activity of OSM, with both mature protein and pro-OSM 
having equal affinity to the receptor, but the presence of this pro-peptide greatly lowers the 
inhibitory activity of OSM9. 
Another example is interleukin-6 (IL-6). Like OSM, IL-6 has a hydrophobic signal peptide on 
the N-terminal side of the protein which is removed during secretion of the protein. 
Interestingly, the location of the cleavage site on IL-6 seems to be important in regard to further 
modifications. When the signal peptide had been cleaved off N-terminally to the 28th amino 
acid (an alanine), IL-6 had O-linked glycosylations, while IL-6 with the new N-terminal at the 
30th amino acid (a valine), had either N-linked glycosylation or both O- and N-linked 
glycosylations10. 
 
These two proteins are only two of numerous examples of regulation of protein activity through 
modification of the N- and C-terminus. 
 
1.3 Top-down and bottom-up proteomics approaches 
With the availability of gene and genome sequence databases and instrument improvements, 
the use of Mass Spectrometry (MS) has become an increasingly common way to approach 
proteomics11. 
 
In MS-based proteomics there are two main approaches: top-down and bottom-up. 
In short, the top-down approach uses MS to fragment entire proteins and gives information on 
the molecular weight for both protein and the peptide fragments. This could yield information 
on the primary structure of the protein, as well as its modifications. However, the top-down 
approach can be difficult to apply to complex samples, such as whole proteome samples, and 
usually requires some sort of “simplification” through e.g. fractionation.12 The technical 
limitations of MS-instruments also puts a cap on protein size that can be ionized and 
fragmented, which makes analysis of large proteins difficult. 
 
The bottom-up approach digests proteins enzymatically before analysis by MS. The total 
protein coverage is typically lower than what can be seen in the top-down approach, and some 
information on PTMs can be lost12. However, since many of the peptide fragments are unique 
for the parent protein, identification and quantification of the proteins present in a sample can 
be successful, though skewed in favour of abundant proteins. 
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Due to the nature of this thesis, enrichment of terminal peptides, the bottom-up proteomics is a 
rather obvious choice of approach. Figure 1-3 shows a typical workflow for bottom-up 
proteomics, using Proteome Discoverer software for data analysis. Other data analysis software 
options (such as e.g. PEAKS Studio or MaxQuant) are available. 
 
 
Figure 1-3: Typical workflow for Bottom-up proteomics (image from http://www.planetorbitrap.com/bottom-up-proteomics) 
 
1.3.1 Terminomics 
As mentioned in 1.2.1 the terminal parts of proteins can contain a lot of valuable information. 
Identifying and quantifying these peptides and the changes made to them could help with the 
understanding of the biological processes involved in diseases and other “out-of-the-ordinary” 
biological states. Terminomics, or positional proteomics, is a field within proteomics that deals 
with these parts of the proteins. Terminomics can be further divided into N-terminomics and 
C-terminomics which focuses on different ends of the protein. 
 
Combined fractional diagonal chromatography (COFRADIC) was one of first techniques  
utilize a negative selection approach to analyse N-terminal peptides. The method, developed 
by Gevaert et al., labels α- and ϵ-amine on protein level and fractionates the resulting peptide 
mixture by reverse-phase HPLC (RP-HPLC). After fractionation, the free α-amines of internal 
and C-terminal peptides are labelled using 2,4,6-trinitrobenzensulfonic acid, a highly 
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hydrophobic molecule. The fractions are then separated with a second RP-HPLC run using the 
same settings and parameters, removing the internal and C-terminal peptides from the fraction, 
before analysis by LC-MS/MS13. 
 
Terminal amine isotopic labelling of substrates (TAILS), is another negative selection 
technique used for enrichment and analysis of N-terminal peptides. As with COFRADIC, 
TAILS labels α- and ϵ-amines on a protein label, typically using formaldehyde or isobaric tags. 
Unlabelled, internal and C-terminal peptides are then removed using an amine reactive 
enrichment agent, and the samples can be analysed using LC-MS/MS. 
 
On the C-terminal side, the development of techniques has been somewhat slower. Lower 
reactivity of the carboxy-groups and the lack of basic amino acids on the neo-N-termini of C-
terminal peptides complicates the C-terminomic approach. However, both COFRADIC14 and 
TAILS15 have been modified to work with C-terminal peptides, and new methods are emerging. 
 
A method published in 2017 by Duan & Xu, termed Profiling of Protein C-termini by 
Enzymatic Labelling (ProC-TEL). ProC-TEL uses a positive enrichment approach labelling, 
using carboxypeptidase Y to label a methyl-esterified terminal carboxy-group with biotin. The 
proteins are then separated using gel electrophoresis; before reduction and alkylation of 
disulphide bonds, and digestion. After being extracted from the gel, biotinylated peptides are 
bound to an enrichment medium while unlabelled peptides are removed. C-terminal peptides 
can then be eluted from the enrichment medium and analysed using MS/MS. 
 
1.4 Protein and peptide processing 
1.4.1 Protein denaturation 
To improve efficiency of the digestion enzyme, the proteins should be denatured to increase 
the number of cleavage sites available. This commonly done using anionic detergents, such as 
sodium dodecyl sulphate (SDS) or sodium deoxycholate (SDC). The detergent interferes with 
the hydrophobic interactions within the protein, causing the protein to lose the its tertiary 
structure17. If the protein sample is prepared from cell cultures, the detergent should be added 
before cell lysis, as it has lysing properties, as well as solubilizing properties which separates 
hydrophobic proteins from its lipid rich environment. 
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After unfolding, a disulphide reducing agent — such as dithiothreitol (DTT) or 2-
mercaptoethanol — can access disulphide bridges normally buried in the interior of the protein, 
and reduce these to further denature the protein. After reduction of the disulphide bridges, the 
sulfhydryls can be alkylated, using an alkylation agent such as iodoacetamide, to prevent 
reformation of disulphide bonds. 
 
1.4.2 Protein digestion 
A handful of proteases are available for use in proteomics, each with a more or less specific 
cleavage site19. This thesis will focus on the serine proteases trypsin and chymotrypsin. 
Trypsin and chymotrypsin have identical mechanisms of action (shown in Figure 1-4), but have 
different specificities. Due to a negatively charged aspartate in the 189-position, trypsin has a 
specificity for long, positively charged amino acids (arginine, lysine) when these are not 
immediately followed by proline. Chymotrypsin has a charge neutral serine in this position, 




Figure 1-4: Serine protease mechanism of action 
 
1.4.3 Peptide labelling 
In order to protect the desired peptides from removal during the enrichment process, the reactive 
groups need to be deactivated. Amines can be protected in several different ways, depending 
on the purpose of the experiment. Some examples are methylation, acetylation or reaction with 
1-Flouro-2,4-dinitrobenzen. 
Carboxy groups can be protected using e.g. ethanolamine or N,N-dimethylethylenediamine. 
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1.5 Enrichment of terminal peptides 
After digestion of proteins in whole proteome samples, the resulting peptide mixture is rather 
complex. The two terminal peptides constitute only a small part of the entire protein and will 
therefore be present in low concentrations compared to internal peptides. To reduce complexity 
and increase the proportion of terminal peptides, the peptide mixture must be enriched21. 
 
N-termini positive selection enrichment focuses on labelling α-amines in a way that allows α-
amine containing peptides to be retained, while unwanted peptides are removed from the 
peptide mixture. E.g. one could label lysine ϵ-amines using O-methylisourea before labelling 
protein α-amines using biotin. After digestion, the peptide solution can be passed through 
immobilized streptavidin, retaining biotin labelled peptides. With the non-biotin labelled 
peptides removed, the biotin-streptavidin bond can be reduced, and the labelled peptides 
eluted22. Known problems with positive selection enrichment are the difficulty in differentiating 
between α- and ϵ-amine when labelling amines, without added steps; as well as trouble labelling 
N-termini with naturally occurring modifications, such as acetylation. 
 
N-termini negative selection enrichment, which this thesis will comprehend, labels both α- and 
ϵ-amines on protein level, preventing further reactions. After digestion the enrichment medium 
binds to the α-amine of neo-N-termini, and is then removed so that only peptides with 
inactivated amines remain23,24. E.g. one could label free amines using reductive dimethylation 
and then digest the proteins in the sample. After digestion, HPG-ALD polymer can be added to 
the sample along with a reductive agent, such as cyanoborohydride, to bond with the amine 
group of neo-N-termini. The polymer can then be removed through filtration, leaving only 
dimethylated peptides in the sample25. 
 
The enrichment of C-termini is challenging due to the lower reactivity of carboxy-groups 
compared to amine-groups26, but the principles are the same as with N-terminal enrichment: 
positive enrichment binds desired peptides to the enrichment medium, and negative selection 




2 Aims of the Study 
The aim of this master thesis is to:  
• Develop and compare different methods for N-terminal enrichment. 
• Using the best method from N-terminal enrichment to develop a method for enrichment 
of C-terminal peptides.  
• Isolation and identification of N-terminal and C-terminal peptides from a complex 





Table 3-1: List of chemicals 




2-(N-Morpholino)ethanesulfonic acid monohydrate 
(MES) 
69892-25G Sigma 
α-Chymotrypsin from bovine pancreas (chymo) C7762-25MG Sigma 
Acetone 32201-1L Sigma-Aldrich 
Acetonitrile (ACN) 34851-2.5L Sigma-Aldrich 
Amine-terminated magnetic particles (NH2-beads) I7643-5ML Sigma 
Ammonium acetate PA 1.1116-1 KEBO Lab 
Benzylamine 13180 Fluka 
Calcium chloride 21074-1KG Sigma-Aldrich 
Dithiothreitol (DTT) D5545-5G Sigma-Aldrich 
Endoproteinase Lys-C (Lys-C) unknown unknown 
Ethanol 24106-2.5L-R Sigma-Aldrich 
Formaldehyde solution, 37% 252549-1L Sigma-Aldrich 
Formic acid ≥ 98% (FA) 33015-1L Sigma-Aldrich 
Glycine HCl A1067,1000 AppliChem 
Guanidine hydrochloride 50950-1KG Sigma 
Hydrochloric acid 30721-1L-GL Sigma-Aldrich 
Hydroxylamine hydrochloride 55459-50G Fluka 
Iodoacetamide (IAA) I6125-10G Sigma 
L-Tryptophan T0254-5G Sigma-Aldrich 
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MilliQ-water  (H2O) - Millipore (USA) 
N-acetyl DL Tryptophan (Ac-Trp) A6251-5G Sigma 
N-Hydroxysuccinimide (NHS) 130672-25G Sigma 
N,N-Dimethylethylenediamine (N,N-DMEDA) D158003-100G Sigma 
NHS Mag Sepharose™ (NHS-beads) 28-9513-80 GE Healthcare 





Sodium cyanoborohydride 156159-10G Aldrich 
Sodium deoxycholate (SDC) D6750-25G Sigma-Aldrich 
Triethylammonium bicarbonate (TEAB) T7408-100ML Sigma 




Trypsin T6567-5X20UG Sigma-Aldrich 
Urea 33247-250G Sigma-Aldrich 
 
The Lys-C was a vial of stock solution from the -20˚C-freezer in the lab, that has since been 
misplaced and cannot be found. The information on production date, concentration and initials 




Table 3-2: List of equipment and materials 
Material/equipment Description Manufacturer/provider 
Biofuge Fresco Centrifuge Heraeus Instruments 
Bond Elute OMIX,  
96 C18 100 uL 
Desalting pipette tip Agilent Technologies 
Centrifugal Filter 
Modified PES 30K, 500 µL 
Purification filter VWR 




EASY-nLC 1000 nLC-instrument Thermo Scientific 
Eppendorf Protein LoBind  
 
Sample vials, 0.5 mL/1.5 mL Eppendorf 
FALCON tube 15mL Sample vial 
Stock solution storage 
Eppendorf 
Heraeus Megafuge 16 Centrifuge Thermo Scientific 
MagNA Lyser Green Beads vial and beads for cell lysis Roche 
MagNA Lyser instrument cell lysis instrument Roche 
MagRack 6 Magnet rack GE Healthcare 
MaxQuant Data analysis Max Planck Institute of 
Biochemistry 







Mini Star Silverline Microcentrifuge VWR 







Parafilm “M” Clingfilm for sample vial 
covering. 
Bemis 
PEAKS Studios 8 Data analysis Bioinformatics Solutions 
Inc. 
Pierce Low Protein Binding 
Microcentrifuge Tubes, 2.0 mL 
Sample vial, 2 mL Thermo Scientific 
Pierce ™ BCA Assay Kit BSA standard and working 
reagent for determination of 
protein concentration. 
Thermo Scientific 





Q Exactive™ hybrid 
quadrupole-Orbitrap™ mass 
spectrometer 
MS-instrument Thermo Scientific 





Termaks Inkubator Incubator Termaks AS 




4.1 Sample preparation 
The steps described in 4.1 were used for preparation of all samples, regardless of whether they 
were to be N-terminal enriched or C-terminal enriched. 
 
4.1.1 Cell lysis 
1. Centrifuged and frozen Escherichia coli (ATCC® 25922™) culture aliquots were 
retrieved from a -80˚C freezer, and thawed at room temperature (RT). 
2. To remove possible contaminants, the E. coli pellets were centrifuged at 16,000 × g, 
before removing the supernatant and washing with 200 µL H2O. The process was then 
repeated. 
3. After the second wash, the pellet was re-suspended in 500 µL lysis buffer, consisting of 
100mM TEAB and 2% SDC. 
4. The resuspended cell culture was transferred to MagNA Lyser Green Beads-vials, and 
lysed using the MagNA Lyser instrument at 7,000 RPM for 50 seconds. 
 
4.1.2 Determination of protein concentration 
Protein concentration was determined using a Pierce™ BCA Assay Kit from Thermo Scientific, 
with the microplate procedure as described by the user guide27. 
1. BCA Assay standards were prepared with six dilutions of Bovine Serum Albumin 
(BSA) in 5 mM TEAB, with BSA concentrations ranging from 0–250 µg/mL. 
2. The protein sample was prepared in five dilutions in 5 mM TEAB, ranging from 1:20–
1:1000 of original concentration. 
3. 25µL of standards and sample dilutions were pipetted into a 96-well microplate in three 
parallels, and 200 µL of working reagent added were added to the microplate wells. 
4. The microplate was incubated with gentle agitation for 30 minutes at 37 ˚C. 
5. After incubation, the plate was cooled at RT for 10 minutes before absorbance was 
recorded on the microplate reader at 562 nm. 
 
4.1.3 Reduction and alkylation of disulphide bridges 
1. The desired amount of protein, calculated using the results obtained from the BCA 
Assay, was transferred to a 1.5mL Eppendorf Protein Lo-Bind-tube and diluted to the 
desired concentration using 100mM TEAB. 
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2. The disulphide bridges were reduced by adding 200 mM dithiothreitol (DTT) to the 
samples, to a concentration of 5 mM DTT. The sample was then incubated with gentle 
agitation in a Termaks Incubator for 30 minutes at 54 ˚C. 
3. After incubation, the sample was cooled at RT for 10 minutes. 
4. When the sample was cooled to RT, the cysteine sulfhydryls were carbamidomethylated 
by adding 600 mM iodoacetamide (IAA) to a final concentration of 15 mM and 
incubating the samples in the dark at RT for 30 minutes. 
5. To remove excess IAA in the sample, DDT was added to a final concentration of 5 mM 
a second time, followed by incubation for 10 minutes at RT. 
 
4.2 Methods for enrichment of N-terminal peptides 
 
Figure 4-1: N-terminal enrichment process overview 
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4.2.1 Dimethyl labelling of N-termini and lysines 
Dimethylation of protein N-termini and lysine ϵ-amines was accomplished through reductive 
methylation. Three different methods were tested, utilizing different reagents for quenching the 
reaction. 
 
4.2.1.1  Dimethylation using glycine and hydroxylamine for quenching 
1. The dimethyl labelling solution was prepared by weighing sodium cyanoborohydride 
(NaBH3CN) in a 1.5 mL Eppendorf Safe-Lock, and then adding TEAB, CH2O and H2O 
to concentrations of 200 mM NaBH3CN, 100 mM CH2O, and 100 mM TEAB. 
2. The labelling solution was added to the protein sample, to a final concentration of 40 
mM NaBH3CN and 20 mM CH2O, and the sample was vortexed for 10 seconds. 
3. The sample was incubated for two hours at 37 ˚C with gentle agitation. 
4. After two hours, an additional 50% of labelling buffer volume was added. The sample 
was vortexed for 10 seconds and left in the incubator with gentle agitation for additional 
30 minutes. 
5. After labelling, excess CH2O was quenched by adding 1.2 M glycine hydrochloride to 
a final concentration of 60 mM. The sample was vortexed for 10 seconds and incubated 
for 10 minutes at RT. 
6. 2.6 M hydroxylamine hydrochloride was added to a final concentration of 130 mM. The 
sample was vortexed for 10 seconds and incubated for 15 minutes at RT. 
 
4.2.1.2 Dimethylation using ammonium acetate and hydroxylamine for quenching 
5. Step 1–4 is performed as described in 4.2.1.1. 
6. Excess CH2O was quenched by adding 1.2 M ammonium acetate to a final concentration 
of 60 mM. The sample was vortexed for 10 seconds and incubated for 10 minutes at 
RT. 
7. 2.6 M hydroxylamine hydrochloride was added to a final concentration of 130 mM. The 
sample was vortexed for 10 seconds and incubated for 15 minutes at RT. 
 
4.2.1.3 Dimethylation using only hydroxylamine for quenching 
5.  Step 1–4 is performed as described in 4.2.1.1.  
6. Excess CH2O was quenched by adding 2.6 M hydroxylamine to a final concentration of 
130 mM. The sample was vortexed for 10 seconds and incubated for 30 minutes at RT. 
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4.2.2 Sample clean-up 
There were three different methods of sample clean-up tested for enrichment of N-terminal 
peptides. 
 
4.2.2.1 Acid precipitation of detergent 
Precipitation of SDC was the only sample clean-up method performed after protein digestion. 
1. After digestion, trifluoroacetic acid (TFA) was added to the sample to a final 
concentration of 1%. 
2. The sample was centrifuged for 20 minutes at 16,000 × g. 
3. After centrifugation the supernatant was carefully pipetted out and transferred to a new 
sample tube and the remaining pellet was discarded. 
 
4.2.2.2 Ethanol precipitation of proteins 
1. The sample was transferred to a 15mL test tube, and 10x sample starting volume of ice 
cold EtOH was added. 
2. The sample was chilled at -20 ˚C for at least 1 hour. 
3. After cooling, the sample was centrifuged for 30 minutes at 4692 × g and 4 ˚C. 
4. The supernatant was removed, and the pellet was washed with 500µL ice-cold acetone  
5. After centrifugation for 5 minutes at 4692 × g, the supernatant was removed, and the 
sample was dried for 30 minutes at RT. 
 
4.2.2.3 Filter aided sample preparation (FASP) 
This clean up method, and subsequent digestion, is a modified version of a method published 
by Pasing et al. in 2016 for use with hydrophobic samples28. 
The amount of protein per filter was limited to 200–250 µg to prevent the filters from possibly 
getting clogged.  
1. 100 µL washing buffer, consisting of 8.0 M urea and 100 mM TEAB, was added to the 
filter(s). The filter was then centrifuged for 20 minutes at 16,000 × g and 21 ˚C, and the 
liquid was discarded. 
2. The sample was added to the filter(s), followed by centrifugation for 20 minutes at 
16,000 × g and 21 ˚C. The liquid was discarded. 
3. 200 µL washing buffer was added to the sample, followed by centrifugation for 20 
minutes at 16,000 × g and 21 ˚C. The liquid was discarded. 
This step was repeated twice using 100 µL washing buffer. 
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4. 100 µL of 100 mM TEAB was added to the sample, followed by centrifugation for 20 
minutes at 16,000 × g and 21 ˚C. The liquid was discarded. 
This step was repeated twice. 
5. Digestion of the protein samples was performed using either trypsin of chymotrypsin as 
described in 4.2.3, using 200 µL of the appropriate digestion solution. After digestion 
the sample was centrifuged for 20 minutes at 16,000 × g and 21 ˚C. 
6. 50 µL 100mM TEAB was added to the sample, followed by centrifugation for 20 
minutes at 16,000 × g and 21 ˚C.  
7. 50 µL H2O was added to the sample, followed by centrifugation for 20 minutes at 
16,000 × g and 21 ˚C. 
8. The sample was desalted as described in 4.2.4. 
 
4.2.3 Protein digestion 
4.2.3.1 Trypsin 
1. Calcium chloride (CaCl2) was added to the sample, to a final concentration of 1 mM. 
If FASP had been used for purification, 200 µL of 100 mM TEAB and 1 mM CaCl2 
were added to the sample on the filter. 
2. Trypsin was added to the sample at an enzyme:protein ratio of 1:20 (w/w). 
The sample was carefully aspirated and dispensed 10 times using a micropipette. 
3. The sample was incubated for 18 hours at 37 ˚C, with gentle agitation. 
 
4.2.3.2 Chymotrypsin 
1. CaCl2 was added to the sample, to a final concentration of 10 mM. 
2. Chymotrypsin solution was added to the sample at an enzyme:protein ratio of 1:20 
(w/w). The sample was carefully aspirated and dispensed 10 times using a micropipette. 
3. The sample was then incubated for 18 hours at 25 ˚C, with gentle agitation. 
 
4.2.3.3 Trypsin with Lys-C pre-digestion 
1. Lys-C was added to the sample at an enzyme:protein ratio of 1:100 (w/w). 
2. The sample was incubated for 6 hours at 37 ˚C, with gentle agitation. 
3. Calcium chloride (CaCl2) was added to the sample, to a final concentration of 1 mM. 
4. Trypsin was added to the sample at an enzyme:protein ratio of 1:20 (w/w). 
The sample was carefully aspirated and dispensed 10 times using a micropipette. 
5. The sample was incubated for 18 hours at 37 ˚C, with gentle agitation. 
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4.2.4 Desalting 
The desalting was performed using the OMIX C18 100 µL-tip, following the manufacturers 
protocol with some changes made to better accommodate this experiment. 
1. TFA was added to the sample, to a final concentration of 1%. 
If method 4.2.2.1 was used for sample clean-up, this step was skipped, as TFA had 
already been added. 
2. Conditioning buffer (50% ACN in H2O) was aspirated and then dispensed as waste. 
This was done twice. 
3. Equilibration buffer (1% TFA in H2O) was aspirated and then dispensed as waste. This 
was done twice. 
4. The sample was slowly aspirated and dispensed 10 times. 
If the sample volume was >1000 µL, aspiration and dispensing was repeated as many 
times as needed to ensure that the total sample volume had passed through the column. 
5. Rinsing buffer (0.1% TFA in H2O) was aspirated and dispensed as waste. This was done 
twice. 
6. Elution buffer (0.1% FA and 80% ACN in H2O) was aspirated and then dispensed in a 
new sample vial.  
If the amount of protein in the sample was over 79 µg*, steps 3–6 were repeated as many 
times as needed to desalt the total amount of protein in the sample. 
7. The elution buffer was evaporated using the CentriVap at 60 ˚C. 
8. The sample was reconstituted with 100mM TEAB, to a concentration of 1–2 µg/µL. 
 
4.2.5 Enrichment of N-terminal peptides 
4.2.5.1 Enrichment using NHS Mag Sepharose™ (NHS-beads) 
1. The NHS-beads were pipetted over to an Eppendorf Protein LoBind 1.5 mL sample vial, 
and the liquid was removed. 
2. The beads were washed three times using a volume of 100 mM TEAB equal to the 
volume of NHS-beads, vortexing the beads for 10 seconds, and removing the liquid 
using the magnet rack and a micropipette. 
3. The sample was added to the beads and incubated for 2 hours at 37 ˚C while shaken 
using a MS 1 Minishaker at 1000 RPM, to make sure the beads didn’t sink to the bottom. 
                                               
* Maximum loading capacity according to the manufacturer. 
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4. After incubation, the sample vial was placed in the magnet rack and the liquid was 
transferred to a new sample tube. 
5. The NHS-beads were washed with ¼ × sample volume and vortexed for 10 seconds. 
The liquid was combined with the one from step 4.  
This was repeated once. 
6. The liquids were combined, and the beads discarded. 
7. The sample was desalted and dried following the procedure described in 4.2.4, skipping 
the final step, and then analysed. 
 
4.2.5.2 Enrichment using polymer-bound 4-Benzyloxy-2,6-dimethoxybenzaldehyde (ALD-
beads) 
1. The ALD-beads were weighed out in a n Eppendorf Protein LoBind1.5 mL sample vial. 
2. To remove possible contaminants, the beads were washed with 100 mM TEAB. The 
beads were spun down using a microcentrifuge, and the liquid was discarded. This 
process was repeated three times. 
3. The sample solution was added to the beads, along with NaBH3CN to a final 
concentration of 40mM. 
4. The sample was incubated for 2 hours at 37 ˚C, while shaken vigorously using a MS 1 
Minishaker at 1000 RPM, to make sure the beads didn’t sink to the bottom. 
5. 1.2M glycine was added to a final concentration of 60 mM, before incubating for 10 
minutes at RT,  
6. NH2OH was added to a final concentration of 130 mM and incubated for another 15 
minutes at RT. 
7. The beads were spun down using the microcentrifuge, and the liquid was transferred to 
a new sample vial. 
8. The ALD-beads were washed with ¼ × sample volume and vortexed for 10 seconds. 
The liquid was combined with the one from step 7. This was repeated twice. 
9. The liquids were combined, and the beads discarded. 
10. The sample was desalted and dried following the procedure described in 4.2.4, 
skipping the final step, and then analysed. 
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4.3 Method for enrichment of C-terminal peptides 
This method used 200 µg protein from a stock of previously lysed, reduced and alkylated 
proteins. The stock had a protein concentration of 1.85 µg/µL, making the starting volume of 
the sample 108.1 µL. 
 
Figure 4-2: C-terminal enrichment process overview 
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4.3.1 Dimethylation of N-termini and lysine ϵ-amines 
The method described in 4.2.1.1 was used to label primary amines. 
1. 27 µL labelling buffer was added to the sample. 
2. The sample was incubated for 2 hours at 37 ˚C, with gentle agitation. 
3. 13.5 µL labelling buffer was added, and the sample was incubated for an additional 30 
minutes at 37 ˚C, with gentle agitation 
4. 7.82 µL of 1.2 M glycine hydrochloride was added, to a final concentration of 60 mM, 
and the sample was incubated for 10 minutes at RT, with gentle agitation. 
5. 8.23 µL 2.6 M hydroxylamine solution was added, to a final concentration of 130 mM, 
and the sample was incubated for 15 minutes at RT, with gentle agitation. 
 
4.3.2 FASP 
The sample was processed using a modified version of the FASP method from 4.2.2.3. 
The liquid was discarded after every step. 
1. 100 µL washing buffer was added to the filter. The filter was then centrifuged for 20 
minutes at 16,000 × g and 21 ˚C. 
2. The sample was added to the filter(s), followed by centrifugation for 20 minutes at 
16,000 × g and 21 ˚C. The liquid was discarded. 
3. 200 µL washing buffer was added to the sample, followed by centrifugation for 20 
minutes at 16,000 × g and 21 ˚C. The liquid was discarded.  
This step was repeated twice using 100 µL washing buffer. 
4. 100 µL of 100 mM TEAB was added to the sample, followed by centrifugation for 20 
minutes at 16,000 × g and 21 ˚C. The liquid was discarded. 
This step was repeated once. 
5. The sample was washed with 100 µL H2O and was centrifuged for 20 minutes at 16,000 
× g and 21 ˚C. The liquid was discarded. 
6. The sample was washed with 100 µL 200 mM MES/2.0 M guanidine and was 





4.3.3 Labelling of C-termini and aspartate/glutamate carboxylates 
1. The sample was reconstituted on the filter with 89.1 µL 500 mM MES, 89.1 µL 5M 
guanidine and 29.8 µL N,N-dimethylethylenediamine (N,N-DMEDA). 
2. pH was adjusted to 4–5 using 32 µL 12M HCl. 
3. 12.16 µL 200 mM NHS/400 mM EDC solution was added, to a final concentration of 
10mM NHS and 20 mM EDC, and the sample was left to incubate at RT for 1 minute 
before measuring pH. 
4. After checking that the pH ≈ 5, the sample was incubated for one hour at 25 ˚C. 
5. 12.8 µL of NHS/EDC solution was added, and the pH was checked after incubating at 
RT for one minute; pH ≈ 5. 
6. The sample was incubated at 25 ˚C for another hour, with gentle agitation. 
7. 13.48 µL NHS/EDC solution was added, and the pH was checked after incubating at 
RT for one minute; pH ≈ 5. 
8. The sample was incubated for 16 hours. 




The liquid was discarded after every step. 
1. The sample was washed with 200 µL H2O and centrifuged at 16,000 × g and 21 ˚C. 
2. The sample was washed with 100 µL H2O and centrifuged at 16,000 × g and 21 ˚C. 
3. The sample was washed twice with washing buffer. After every wash the sample was 
centrifuged at 16,000 × g and 21 ˚C. 
4. The sample was washed twice with 100 µL 100 mM TEAB. After every wash the 
sample was centrifuged at 16,000 × g and 21 ˚C. 
 
4.3.5 Digestion 
The method in 4.2.3.1 was used for digestion, with a few steps added. 
1. 200 µL 100 mM TEAB and 1 mM CaCl2 was added to the sample. 
2. 10 µL 1 µg/µL trypsin was added to the sample. To mix, the sample was carefully 
aspirated and dispensed 10 times with a micropipette. 
3. The sample was incubated for 18 hours at 37 ˚C, with gentle agitation. 
4. The sample was centrifuged for 20 minutes at 16,000 × g and 21 ˚C. 
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5. The sample was washed with 50 µL 100 mM TEAB and centrifuged for 20 minutes at 
16,000 × g and 21 ˚C. 
6. The sample was washed with 50 µL H2O and centrifuged for 20 minutes at 16,000 × g 
and 21 ˚C. 
7. The liquids were combined in a sample vial, and the filter was discarded. 
 
4.3.6 Dimethylation of neo-N-termini 
The method described in 4.2.1.3 was used to label neo-N-termini amines. 
1. 77.5 µL labelling buffer was added. 
2. The sample was incubated for 2 hours at 37 ˚C, with gentle agitation. 
3. 38.8 µL labelling buffer was added. 
4. The sample was incubated for 30 minutes at 37 ˚C, with gentle agitation 
5. 22.4 µL 2.6 M NH2OH solution was added, to a final concentration of 130 mM. 
6. The sample was incubated for 30 minutes at RT, with gentle agitation. 
 
4.3.7 Desalting 
The desalting was performed using the OMIX C18 100 µL-tip, following the manufacturers 
protocol with some changes made to better accommodate this experiment. 
1. HCl was added to the sample, to a final concentration of 75 mM. 
2. Conditioning buffer (50% ACN in H2O) was aspirated and then dispensed as waste. 
This was done twice. 
3. Equilibration buffer (75 mM HCl) was aspirated and then dispensed as waste. This was 
done twice. 
4. The sample was slowly aspirated and dispensed 10 times. 
5. Rinsing buffer (20 mM HCl) was aspirated and dispensed as waste. This was done 
twice. 
6. Elution buffer (0.1% FA and 80% ACN in H2O) was aspirated and then dispensed in a 
new sample vial.  
7. Steps 3–6 was repeated two more times, combining the eluate from the 6. step in the 
same sample vial. 




4.3.8 C-terminal enrichment using amine terminated magnetic particles (NH2-beads) 
1. After desalting, the sample was reconstituted with 500 µL 200 mM MES/2 M guanidine. 
2. 100µL NH2-beads were pipetted over to a 1.5 mL sample vial on the MagRack6, and 
the liquid was removed. 
3. To remove possible contaminants, 500 µL of 200 mM MES/2.0 M guanidine equal to 
the volume of NH2-beads were added, and the beads were vortexed for 10 seconds. The 
vial was then placed on the MagRack6 to remove and discard the supernatant. This 
process was repeated three times. 
4. The sample was added to the beads, and 55.6 µL 100 mM NHS/500 mM EDC solution 
was added, to a final concentration of 10 mM NHS and 50 mM EDC. 
5. After 1 minute the pH was controlled; pH ≈ 4–5. 
6. The sample was incubated for 3 hours at 25 ˚C while shaken vigorously, using a MS 1 
Minishaker at 1000 RPM, to make sure the beads didn’t sink to the bottom.  
7. 61.7 µL NHS/EDC solution was, and after one minute the pH was controlled; pH ≈ 5. 
8. The sample was incubated for 16 hours at 25 ˚C, while shaken vigorously. 
9. The sample was placed in a MagRack6 and the liquid was pipetted to a new sample vial. 
10. The NH2-beads were washed with 200µL MES/guanidine buffer, and the beads were 
vortexed for 10 seconds. This was repeated once. 
11. The liquids from step 10 were combined with the liquid from step 9, and the beads were 
discarded. 
12. The samples was desalted and dried following the procedure described in 4.2.4, 
skipping the last step, and then analysed. 
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4.4 Sample analysis 
The steps described in 4.4 were used for analysis of all samples, regardless of whether they 
were to be used in N-terminal enrichment or C-terminal enrichment. 
 
4.4.1 Determining peptide concentration 
Before the nLC-MS/MS analysis, the peptide concentration was determined with 
spectrophotometry using a NanoDrop™1000 spectrophotometer and the “Protein A280” 
setting. Absorbance was measured at λ = 205nm. 
1. The sample was reconstituted in 10 µL 0.1% TFA. 
2. The spectrophotometer was conditioned with 2 µL H2O. 
3. 2 µL 0.1% TFA was used to set a reference point. 
4. A “blank” sample of 2 µL 0.1% TFA was ran. 
5. Added 2 µL of the sample, and measured absorbance in 4 parallels. 
If more than one sample had the concentration measured in quick succession, step 3–5 
was repeated for as many times as needed. 
 
4.4.2 nLC-MS/MS 
The nLC-MS/MS analysis was performed with a Thermo Scientific™ Q Exactive™ Hybrid 
Quadropole-Orbitrap™ Mass Spectrometer, connected to a Thermo Scientific™ EASY-nLC™ 
1000 Liquid Chromatograph. 
 
The nLC utilized a C18 column (2 µm, 100 Å, 75 µm, 50 cm), and two different gradients. 
• A short gradient was 30 minutes long, with 4–40% ACN in 0.1% FA. 
The injection volume was 2 µL, for a total of 0.5 µg peptides in 0.1% TFA 
• A long gradient was 60 minutes long, with 4–8% ACN in 0.1% FA for the first 10 
minutes and 8–40% for the last 50 minutes. 
The injection volume was 3 µL, for a total of 0.75 µg peptides in 0.1% TFA. 




Table 4-1: Q-Exactive settings 
Method of Q Exactive 
OVERALL METHOD SETTINGS  
Global Settings  
Chrom. Peak width (FWHM) 9 s 
Experiment 
FULL MS / DD-MS2 (TOPN)  
General  
Polarity Positive 
Default charge state 2 
Full MS  
Resolution 70,000 
AGC target 1e6 
Maximum IT 100 ms 
Scan Range 400 to 2,000 m/z 
Spectrum data type Profile 
dd-MS2 / dd-SIM  
Resolution 17,500 
AGC Target 1e5 
Maximum IT 60 ms 
Loop count 10 
TopN 10 
Isolation window 2.0 m/z 
(N) CE / stepped (N) CE nce: 28 
Spectrum data type Profile 
dd Settings  
Intensity threshold 3.3e4 




4.4.3 Data analysis 
PEAKS Studio 8.0 was used for data analysis. The settings used can be seen in Table 4-2. 
Table 4-2: PEAKS search settings. 
Error Tolerance Precursor mass 10.0 ppm 
 Fragment ion: 0.05 Da 
Enzyme Specified by each sample  
 Allow non-specific cleavage at 
— — ends of the peptide 
one 
 Maximum allowed variable 
PTM per peptide 
5 
PTM Fixed Carbamidomethylation (all samples) 
 Variable Lysine dimethylation (all samples) 
  N-term dimethylation  
(N-terminal samples) 
  N-term acetylation  
(N-terminal samples) 
  C-term N,N-DMEDA 
(C-terminal samples) 
  Aspartate/glutamate N,N-DMEDA  
(C-terminal samples) 
Database Select database E. coli 
De Novo Tag Options Available de novo tags: DENOVO 2 




Peptide FDR was set to 1% and peptide information was exported as a .csv-file. 
 
The .csv-file was imported in Excel, and was processed using the following functions: 
- Average peptide mass was calculated using =AVERAGE(Mass) 
- The number of peptides was counted using =COUNTIF(*)-1 (-1 to exclude the 
header row) 
- Number of N-terminal peptides was counted =COUNTIF(“?(*”), and then removing 
“false positives” by removing K-leading peptides with only one +28.03 Da 
modification, as well as C-leading peptides without a dimethyl modification. 
- % N-terminal peptides was calculated by =N-term/Peptides 
- The amount of lysines were counted using the function =COUNTIF(“*K*”), and 
the amount of modified lysines (termed Kmod) were counted using 
=COUNTIF(“*K(*”). The ratio was then calculated by = Kmod/K. 
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4.5 Analysis of model systems 
To test whether or not some of the steps used in the enrichment processes worked by principle, 
two simple systems were set up. The N-terminal model used benzylamine as a model substance, 
and the C-terminal model used tryptophan and N-acetyl tryptophan (Ac-Trp). These model 
systems were analysed in a simpler way than the proteome samples, using ultra performance 
LC (UPLC) and triple quadrupole MS (TQMS). Since these model systems were about proof 
of concept, the aim was fast results rather than reproducibility or high accuracy. 
 
The model samples were separated using C18 column (2.5 µm, 100 Å, 1.0 x 50 mm) with a 5-
minute gradient of 1–95% ACN in 0.1% FA and a flow rate of 0.38 mL/min. The injection 
volume was 10 µL. 
After separation the samples were first analysed by the TQMS in full scan mode looking for 
masses (m/z) between 50–500 Da, to look for potential contaminants and the mass of the target 
ions. The samples were then analysed in selected ion recording (SIR) mode, with the MS 
selecting for the specific masses of the ion supposed to be present in the sample. See Table 4-
3 for masses. These masses match the ions found in the complementing MS full scan, which 
may deviate from the calculated masses, as the MS-instrument had not been calibrated in a 
while. 
 
Table 4-3: m/z for selected ions. 
Ion m/z Calculated m/z 
Benzylamine + H+ 107.8 108.15 
Dimethylbenzylamine + H+ 135.8 136.21 
Trp + H+ 205.00 205.23 




5 Results and Discussion 
5.1 Validation of dimethyl labelling 
A sample of 50 µg protein was processed using glycine and hydroxylamine for quenching the 
dimethylation, acid precipitation of SDC for clean up, and trypsin for digestion. Results from 
this sample showed that 97.6% of all lysines had been labelled after processing. 
The lysines in control samples for trypsin digestion and chymotrypsin digestion, as well as in 
three randomly selected samples, were also counted. In these five samples an average of 99.0% 
of lysines were labelled. 
 
One sample had been labelled using a labelling buffer that was a week old, and with this sample 
the importance of using freshly prepared labelling buffer shone through. The PEAKS-searched 
showed that only 5.3% of the lysines had been labelled, and enrichment of the sample yielded 
a mere 15 N-terminal peptides (0.3% of all peptides found). 
 
5.2 Testing of enzyme digestion 
In addition to chymotrypsin and trypsin, a digestion method using endoproteinase Lys-C in 
addition to trypsin was tested. A sample of 50 µg protein was processed using glycine and 
hydroxylamine for quenching the dimethylation, and trypsin for digestion. but before 
trypsination the sample was incubated for 6 hours at 37 ˚C with 0,5 µg Lys-C. The results, 
however, showed that the Lys-C pre-treated sample was only 1.5 percentage points higher in 
peptides ending with a lysine. It has been reported that monomethylation of lysines will inhibit 
Lys-C29, so it would be natural that dimethylation has the same effect. Digestion using Lys-C 
in a pre-digestion step was therefore not investigated any further. 
Digestion using trypsin resulted in fewer peptides in total compared to chymotrypsin, but as 
can be seen in Figure 5-1, the number of N-terminal peptides identified by PEAKS was more 
than double compared to samples that had been digested with chymotrypsin. A possible 
explanation for this is the specificity difference for the two enzymes. 
As mentioned in 1.4.2, trypsin has a specificity for lysine and arginine due to the negatively 
charged aspartate in the 189-position. However, as with Lys-C, dimethylation of lysine greatly 
reduces the specificity of trypsin for lysine, resulting in cleavage almost exclusively at arginine 
leaving a very limited amount of cleavage sites30 —and therefore longer peptides; while the 
specificity for several hydrophilic amino acids in chymotrypsin could give shorter peptides due 
increased amount of cleavage sites. 
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Figure 5-1: Average peptide yield per enzyme 
 
5.3 N-terminal enrichment 
5.3.1 NHS-beads vs. ALD-beads 
17 different samples were set up in parallel to find which of the two bead types would give the 
best results. The samples were set up/prepared according to Table 5-1 and  
 
Table 5-2, and were processed using glycine and hydroxylamine for quenching of the dimethyl 
labelling, acid precipitation of SDC as sample clean-up, and chymotrypsin for digestion. Eight 
of these samples were enriched using the NHS-bead method, and nine were enriched using the 
ALD-bead method. 
 
Table 5-1: NHS-enriched parallels 
Volume Protein Amount of NHS-beads 
1 mL 2 mg 500 µL (NHSA1) 250 µL (NHSA2) 125 µL (NHSA2) 
1 mL 1 mg 500 µL (NHSB1) 250 µL (NHSB2) 125 µL (NHSB3) 




Table 5-2: ALD-enriched parallels 
Volume Protein Amount of ALD-beads 
1 mL 2 mg 15 mg (ALDA1) 5 mg (ALDA2) 1 mg (ALDA3) 
1 mL 1 mg 15 mg (ALDB1) 5 mg (ALDB2) 1 mg (ALDB3) 
0.5 mL 0.5 mg 15 mg (ALDC1) 5 mg (ALDC2) 1 mg (ALDC3) 
 
In general, enrichment using NHS-beads gave a higher number and ratio of N-terminal beads 
than enrichment using ALD-beads, but as can be seen in Figure 5-2 there is only a difference 
of about 10 peptides between the averages. It was therefore chosen to move forward using the 
ALD-beads due to the much lower price of these compared to the NHS-beads. 
 
 
Figure 5-2: Comparison of results from the 17 different parallels 
 
5.3.2 N-terminal enrichment-model using benzylamine 
Due to trouble in achieving a good amount of N-terminal peptides during the first four months, 
a model was set up using benzylamine as a substitute for proteins/peptides. 
0.5 ml of 666 µM benzylamine, in 100 mM TEAB, was processed using both the NHS and the 
ALD enrichment methods. The analysis of these two samples on UPLC with a Triple 
Quadrupole MS (UPLC-TQMS) showed that ≥98% of the benzylamine had been removed from 
the sample. 
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A new sample of 666 µM benzylamine was dimethylated, using glycine and hydroxylamine for 
quenching. The sample was then analysed on UPLC, and the results showed that the labelling 
had been successful. However, when the sample was desalted and analysed again, the results 
showed that glycine was still present after desalting. The presence of glycine in the sample is a 
great problem for the enrichment. With the free amine in glycine, and the rather high amount 
added, glycine can bind to the beads during the enrichment process and lead to loss of peptides. 
This discovery led to a change in the sample clean-up method from detergent precipitation to 
protein precipitation. 
 
5.3.3 Detergent precipitation vs. protein precipitation vs. FASP 
As explained in the results from the benzylamine model, glycine was still present in the sample 
after clean-up using the detergent precipitation and a new method for sample clean-up was 
needed. Ethanol precipitation of proteins was tested as the new method, with three different 
samples containing a different amount of proteins. The samples were labelled using glycine and 
hydroxylamine for quenching, and chymotrypsin for digestion. As can be seen in Table 5-3 the 
results were even worse than before. This is like due to the fact that glycine is insoluble in 
ethanol31, and is precipitating along with the proteins. However, the fourth sample tested using 
ethanol precipitation of proteins, in which the labelling reaction quenched using ammonium 
acetate in place of glycine, still had a much lower number and ratio of N-terminal peptides than 
samples that were processed using the acid precipitation of the detergent. 
 
The third and final clean-up method that were tested was the filter aided sample preparation. It 
was used on only three samples for the N-terminal enrichment. One of these samples, digested 
with trypsin and enriched with NHS-beads, had 221 N-terminal peptides out of a total of 4238 
peptides. While not the highest total number of N-terminal peptides found in a sample, at 5.21% 
it is the highest ratio of N-terminal peptides seen in a processed sample during this project. 
However, this sample was run on a longer gradient than the other samples in the N-terminal 
experiments, and is therefore not necessarily comparable to them. 
 
The two other samples that had been prepared using FASP were both enriched with ALD-beads 
but digested with different enzymes. The chymotrypsin sample had results that was lower than 
what had been seen with similar samples using acid precipitation of detergent as a clean-up 
method (155 N-terminal peptides/2.46% for the FASP-sample, and an average of 205,2 N-
terminal peptides/3.61% for comparable samples. 
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The FASP-sample that had been digested using trypsin, and enriched using ALD-beads, had 
the third highest number of N-terminal peptides seen, but the ratio was somewhat lower 
compared to the sample with the best ratio (4.45% vs. 4.91%). 
 
5.3.4 Summary 
On average, trypsin yielded more N-terminal peptides than chymotrypsin (average 220.33 for 
trypsin and average 185.12 for chymotrypsin). However, the chymotrypsin number if affected 
by the poor performance of ethanol precipitation of proteins (average of 123.7 N-terminal 
peptides), which was only tested using chymotrypsin. If these results are excluded from the 
average, the Number of N-terminal peptide goes up to an average of 204.5. 
 
In the 17 parallels set up, NHS-beads gave slightly more peptides than ALD-beads (216.6 for 
NHS, 205.2 for ALD).  
 
Ethanol precipitation of proteins was only tested using chymotrypsin and ALD-beads, but given 
the low average (123.7 / 2.29% N-terminal peptides), it hard to imagine changing digestion or 
enrichment method would improve this.  
 
The best results in terms of absolute number of N-terminal peptides identified, was a sample 
which underwent detergent precipitation, digested by chymotrypsin and enriched using NHS-
beads. Out of 5805 peptides found by PEAKS in the sample, 231 peptides (3.98 %) had a 
dimethyl modification that implied it was an N-terminal peptide (+28.03 Da for non-lysine N-
terminal amino acids, or  +56.06 Da modifications for N-terminal lysines). 
 
The sample with the best ratio, 5.21 %, of N-terminal peptides was in a sample purified with 
FASP, digested with trypsin and enriched with NHS-beads, which yielded 221 N-terminal 
peptides out of 4238 total peptides. 
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Table 5-3: Results from the N-terminal enrichment 
Sample 
Amount of 
















200 µg Detergent precipitation Chymo NHS-beads 100 µL 1348,96 5362 151 2,82 % 
171018_Trypsin 
_Enrichment 
200 µg Detergent precipitation Trypsin NHS-beads 100 µL 1620,42 4441 218 4,91 % 
180106_ALDA1 2 mg Detergent precipitation Chymo ALD-beads 14.92 mg 1554,56 5756 211 3,67 % 
180106_ALDA2 2 mg Detergent precipitation Chymo ALD-beads 5.07 mg 1610,50 5677 219 3,86 % 
180106_ALDA3 2 mg Detergent precipitation Chymo ALD-beads 0.99 mg 1548,30 5793 201 3,47 % 
180106_ALDB1 1 mg Detergent precipitation Chymo ALD-beads 15.00 mg 1494,56 5831 197 3,38 % 
180106_ALDB2 1 mg Detergent precipitation Chymo ALD-beads 4.99 mg 1523,62 5732 207 3,61 % 
180106_ALDB3 1 mg Detergent precipitation Chymo ALD-beads 1.02 mg 1473,60 5713 208 3,64 % 
180106_ALDC1 0.5 mg Detergent precipitation Chymo ALD-beads 15.01 mg 1475,80 5321 174 3,27 % 
180106_ALDC2 0.5 mg Detergent precipitation Chymo ALD-beads 4.95 mg 1569,02 5625 203 3,61 % 
180106_ALDC3 0.5 mg Detergent precipitation Chymo ALD-beads 1.00 mg 1545,78 5708 227 3,98 % 
180106_NHSA1 2 mg Detergent precipitation Chymo NHS-beads 500 µL 1597,37 5487 220 4,01 % 
180106_NHSA2 2 mg Detergent precipitation Chymo NHS-beads 250 µL 1557,32 5488 228 4,15 % 
180106_NHSA3 2 mg Detergent precipitation Chymo NHS-beads 125 µL 1556,41 5805 231 3,98 % 
180106_NHSB1 1 mg Detergent precipitation Chymo NHS-beads 500 µL 1585,98 5346 221 4,13 % 
180106_NHSB2 1 mg Detergent precipitation Chymo NHS-beads 250 µL 1580,70 5296 217 4,10 % 
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180106_NHSB3 1 mg Detergent precipitation Chymo NHS-beads 125 µL 1530,53 5462 183 3,35 % 
180106_NHSC1 0.5 mg Detergent precipitation Chymo NHS-beads 500 µL 1577,98 5423 210 3,87 % 
180106_NHSC2 0.5 mg Detergent precipitation Chymo NHS-beads 250 µL 1644,90 5081 223 4,39 % 
180208_NoGlyA 0.5 mg Protein precipitation Chymo ALD-beads 2.1 mg 1343,47 5380 123 2,29 % 
180208_NoGlyB 1 mg Protein precipitation Chymo ALD-beads 2.4 mg 1348,31 5310 113 2,13 % 
180208_NoGlyC 2 mg Protein precipitation Chymo ALD-beads 2.2 mg 1347,71 5684 133 2,34 % 
180215_NoGlyD 1 mg Protein precipitation Chymo ALD-beads 1.9 mg 1443,48 5542 148 2,67 % 
180226_ALD10 1.2 mg Protein precipitation Chymo ALD-beads 11.4 mg 1327,35 5074 110 2,17 % 
180226_ALD20 1.2 mg Protein precipitation Chymo ALD-beads 22.1 mg 1320,94 5360 115 2,15 % 
180227_FASP_test 1 mg FASP Chymo ALD-beads 21.1 mg 1434,38 6301 155 2,46 % 
180309_Trypsin_FASP 1 mg FASP Trypsin ALD-beads 11.3 mg 1879,22 4989 222 4,45 % 
180320_Chymo_test 50 µg — Chymo — — 1274,16 3926 119 3,03 % 
180320_Trypsin_test 50 µg — Trypsin — — 1688,64 3417 248 7,26 % 
Same sample as above 
on a long nLC-gradient 
     1797,42 4577 254 5,55 % 
180403_FASP3 0.5 mg FASP Trypsin NHS-beads 500 µL 1765,36 4238 221 5,21 % 
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5.4 C-terminal enrichment 
5.4.1 C-terminal Enrichment-model using tryptophan and N-acetyl tryptophan 
A model using tryptophan and N-acetyl tryptophan (Ac-Trp) was set up to test some of the steps 
in the C-terminal enrichment process, using a modified version of a protocol for C-terminal 
peptide enrichment published by Schilling et al. in Protocol Exchange from Nature Protocols15. 
 
1.3 mg Ac-Trp was dissolved in 1000 µL buffer containing 200 mM MES, 2.0 M guanidine 
and 1M N,N-DMEDA (in the Schilling et al. protocol ethanolamine was used instead of N,N-
DMEDA). The sample was then adjusted to pH 5 using 165 µL 100% TFA. NHS/EDC was 
added to 10/20 mM three times, incubating at 25 ˚C for one hour after the first two additions 
and for 16 hours after the third addition. The pH was controlled 1 minute after every addition 
of NHS/EDC. After the 16-hour incubation, the solution was analysed on UPLC-TQMS to 
confirm that the process had been successful. 
 
Once the N,N-DMEDA and Ac-Trp coupling had been confirmed, a sample of 1 mg tryptophan 
was dimethylated —using N,N-DMEDA for quenching— and desalted. Analysis on UPLC-
TQMS showed that quenching with N,N-DMEDA seemed to have worked, but that a large 
amount of DM-tryptophan appeared to have been removed during the desalting. Therefore, the 
enrichment process itself ended up not being tested using this model. 
 
The labelling process was then tested using a trypsinated protein sample, which was analysed 
with the methods described in 4.4. The PEAKS-search showed very few peptides that had been 
labelled with N,N-DMEDA, but due to time restrictions the experiment was pushed forward to 
the next phase. 
 
5.4.2 Enrichment of C-terminal peptides using amine terminated magnetic particles 
When the data from the sample put through the processes as described in 4.3 was analysed, 
PEAKS found only 61 peptides in the sample. Only two of these peptides had an N,N-DMEDA 
label, and only one of these two peptides had the label C-terminally. This is a far cry from the 




Due to the limited amount of time for this thesis, any further testing to find out what could be 
the problem with the C-terminal was not possible. However, one of the key difficulties during 
this part was working with N,N-DMEDA. The NHS/EDC reaction requires a pH of 4–5, but 
the addition of N,N-DMEDA to 1.0 M brought the pH in the buffer up to 11–12. Lowering the 
pH to 4–5 required a large amount of HCl, which in turn lowered the concentration of both 
N,N-DMEDA and the MES/guanidine.  
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6 Conclusion 
While none of the results have been validated or tested in more than one parallel, it would seem 
that none of the methods presented here would be usable to increase the amount of terminal 
peptides in a complex proteome sample. In theory, the methods should be possible, as similar 
approaches have been reported, with much higher numbers than achieved in this project. 
 
On the N-terminal side, it appears that trypsin gives a higher number of N-terminal peptides — 
at least that could be detected with PEAKS —than chymotrypsin. Additionally, ethanol 
precipitation of proteins as a sample clean-up method seems to give a lower number of N-
terminal peptides compared to acid precipitation of detergent and the FASP method. The FASP 
method and the acid precipitation of detergent gave  similar results. Clearly there are one or 
more variables in our approach that are not under control, or that is treated the wrong way. If 
this variable is found, the approach should give good results based on the currently published 
results.  
 
The method for enrichment of C-terminal peptides was a single test to investigate if it would 
be possible to enrich for C-terminal peptides. However, the results were not positive, 




7 Future Aspects 
The need for a robust protocol for both N-terminal and C-terminal is evident, however in the 
current work there are undisputedly some steps and variables not under control and in further 
need of investigation. Dimethylamine was chosen as an amine label to better mimic the charge 
distribution of tryptic peptides, but this may, for unknown reasons, have introduced problems 
during the enrichment process.  
 
Since the depletion of benzylamine seemed to work, the overall method should be possible, but 
is in need of an in-depth investigation of the variables in sample preparation and enrichment 
methods. 
 
Upon success of the N-terminal enrichment method, the C-terminal enrichment can be 
addressed. Also here should a model system be utilized to investigate the different variables 
such as labelling buffers, labelling reagents, N-terminal labelling, and other variables that might 
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